accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 120 participants.
Also called NCT03863132
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT03863132
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany, Italy, Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03863132. Randomized; no masking; primary purpose treatment. Start 2019-07-03 (actual); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
- Acronym
- REBOOT-PARADOX
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- TAVR (transcatheter aortic valve replacement)
- Lead sponsor
- IHF GmbH - Institut für Herzinfarktforschung
- Collaborator
- Boston Scientific Corporation
- Collaborator
- Yale University
Record details
- Record id
cardio:ct-nct03863132- Content hash
0cbca1976e9d548808ad5d06d9361781c7930d0b6b897c73ff6b697cfb0a7fdb